PMID- 12475455 OWN - NLM STAT- MEDLINE DCOM- 20030115 LR - 20220311 IS - 0735-1097 (Print) IS - 0735-1097 (Linking) VI - 40 IP - 11 DP - 2002 Dec 4 TI - A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. PG - 1955-60 AB - OBJECTIVES: This study was done to identify the best treatment for an isolated high-grade stenosis of the proximal left anterior descending coronary artery (LAD). BACKGROUND: Percutaneous transluminal coronary angioplasty with stenting (PCI) and off-pump coronary artery bypass grafting (surgery) are used to treat single-vessel disease of a high-grade stenosis of the proximal LAD. Midterm results of both treatments are compared in this prospective randomized study. METHODS: In a single-center prospective trial, we randomly assigned 102 patients with a high-grade stenosis of the proximal LAD (American College of Cardiology/American Heart Association classification type B2 or C) to PCI (n = 51) or surgery (n = 51). Primary composite end point was freedom from Major Adverse Cardiac and Cerebrovascular Events (MACCE) at follow-up, including death, myocardial infarction, cerebrovascular accident, and repeat target vessel revascularization (TVR). Secondary end points were angina pectoris class and need for antianginal medication at follow-up. Analysis was by intention-to-treat (ITT) and received treatment (RT). RESULTS: Mean follow-up time was three years (90% midrange, two to four years). Incidence of MACCE was 23.5% after PCI and 9.8% after surgery; p = 0.07 ITT (24.1% vs. 8.3%; p = 0.04 RT). After surgery a significantly lower angina pectoris class (p = 0.02) and need for antianginal medication (p = 0.01) was found compared to PCI. Target vessel revascularization was 15.7% after PCI and 4.1% after surgery (p = 0.09). CONCLUSIONS: At three-year follow-up (range, two to four years), a trend in favor of surgery is observed in regard to MACCE-free survival with a significantly lower angina pectoris status and significantly lower need for antianginal medication. FAU - Drenth, Derk J AU - Drenth DJ AD - Thoraxcentre of the Groningen University Hospital, Groningen, The Netherlands. FAU - Veeger, Nic J G M AU - Veeger NJ FAU - Winter, Jobst B AU - Winter JB FAU - Grandjean, Jan G AU - Grandjean JG FAU - Mariani, Massimo A AU - Mariani MA FAU - Boven van, Ad J AU - Boven van AJ FAU - Boonstra, Piet W AU - Boonstra PW LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - United States TA - J Am Coll Cardiol JT - Journal of the American College of Cardiology JID - 8301365 SB - IM MH - *Angioplasty, Balloon, Coronary/mortality MH - Arteries/*pathology/*surgery MH - Blood Vessel Prosthesis Implantation/mortality MH - Coronary Angiography MH - Coronary Artery Bypass/mortality MH - Coronary Stenosis/diagnostic imaging/epidemiology/*therapy MH - Coronary Vessels/*pathology/*surgery MH - Disease-Free Survival MH - Female MH - Follow-Up Studies MH - Humans MH - Incidence MH - Male MH - Middle Aged MH - Postoperative Complications/epidemiology/etiology MH - Prospective Studies MH - Risk Factors MH - Severity of Illness Index MH - *Stents MH - Treatment Outcome EDAT- 2002/12/12 04:00 MHDA- 2003/01/16 04:00 CRDT- 2002/12/12 04:00 PHST- 2002/12/12 04:00 [pubmed] PHST- 2003/01/16 04:00 [medline] PHST- 2002/12/12 04:00 [entrez] AID - S0735109702025366 [pii] AID - 10.1016/s0735-1097(02)02536-6 [doi] PST - ppublish SO - J Am Coll Cardiol. 2002 Dec 4;40(11):1955-60. doi: 10.1016/s0735-1097(02)02536-6.